Lipid phosphate phosphatase-3 (LPP3) is expressed at high levels in endothelial cells (ECs). Although LPP3 is known to hydrolyse the phosphate group from lysolipids such as spingosine-1-phosphate and its structural homologues, the function of Lpp3 in ECs is not completely understood. In this study, we investigated how tyrosine-protein kinase receptor (TEK or Tie2) promoter-dependent deletion of Lpp3 alters EC activities.
Introduction
Cell-adhesion events mediated by VE-cadherins, catenins, and extracellular matrix (ECM) proteins play decisive roles in the development of vascular endothelial cells (ECs) and the maintenance of the vascular system. 1 -6 In this regard, the pivotal roles played by b-catenin and VEcadherin in the formation of adherens junctions (AJs) during the development and maintenance of blood vessels have been investigated. 1 -6 For example, the deletion of VE-cadherin (Cdh5) was found to inhibit vascular remodelling and induce degradation of vascular integrity, resulting in early embryonic lethality. 3, 4 The conditional deletion of the b-catenin gene in ECs induces a defective vascular pattern and reduces vascular integrity. 5 Cell adhesion mediated by binding of integrins to ECM proteins such as fibronectin and laminins also plays an equally important role in several aspects of vascular development and differentiation. 1,2 A key role for b-catenin beyond binding to VE-cadherin has been established in the transduction of Wnt signals. 7 -10 Canonical
Wnt signalling propagates translocation of stabilized b-catenin to the nucleus, where it coactivates the transcription factor T-cell factor/ lymphocyte enhancer binding factor (TCF-1/LEF-1). 9, 10 In addition, b-catenin also plays a key role in EC and heart valve development and activates transcription factors such as Er71/Etv2, which plays a key role in the generation of Fetal liver kinase (Flk)1 + ECs. 11, 12 However, the molecular mechanisms underlying these processes are not clearly understood. Lipid phosphate phosphatases (LPPs), most recently changed the nomenclature to phospholipid phosphatases (PLPPs), are encoded by phosphatidic acid phosphatases (PPAP2b), represent a family of ectoenzymes that are known to cleave the phosphate group from sphingosine-1-phosphate (S1P) and its structural homologues. 13 -15 The three major isoforms LPP1, LPP2, and LPP3 are distributed unevenly in the endoplasmic reticulum, cytosol, plasma membrane, and caveolae. 13 -17 A more recent study reported the localization of LPP3 to cell -cell contact sites. 18 Previous studies have documented the ability of LPPs to down-regulate cell signalling. 13 -17 We previously detected LPP3 in a bioassay for angiogenesis and reported the ability of LPP3 to regulate cell-adhesion events. 19, 20 We also showed that anti-LPP3 antibody blocked basic fibroblast growth factor (bFGF)-and vascular endothelial growth factor (VEGF)-mediated angiogenic activities of ECs. 21 In addition, we reported the ability of LPP3 to regulate tumour growth in vivo. 21 -23 Conventional deletion of the Lpp3 gene results in severe embryonic developmental abnormalities such as defective formation of the chorioallantois, placenta, and yolk sac vasculature, suggesting a critical function of Lpp3 in early mouse development. 24 Thus, complete analysis of the in vivo function of Lpp3 is hampered by early embryonic lethality. 24 The results obtained on Mx1 Cre -or Cdh5 CreERT2 -mediated deletion of
Lpp3 indicated its ability to control the Lpp3 -S1P steady state in relation to thymic T-cell egression. 25 Lpp3 deletion altered smooth muscle cell phenotypes 26 and vascular inflammation. 27 These studies described the ability of Lpp3 to act as an enzyme; however, they did not address the behaviour of ECs in relation to cardiovascular development. Therefore, we generated Lpp3 fl/fl mice and crossed them with the Tie2
Cre transgenic line; we used these mice to investigate the crucial role played by Lpp3 in EC barrier integrity and cardiovascular development.
Methods

Materials and methods
Antibodies and reagents
Production, characterization, and use of rabbit anti-LPP3 antibody have been previously described, 19 -22 and anti-LPP3 antibodies were used at 1.5 mg/mL concentration. Mouse anti-VCIP/LPP3 (39-1000) monoclonal antibody (mAb) was purchased from Invitrogen (Carlsbad, CA, USA), used at 2.0 mg/mL concentration. Rabbit-anti-LPP2 polyclonal antibody (pAb) was obtained from Exalpha Biologicals, Inc. (Shirley, MA, USA), prepared and used at 2.0 mg/mL. Rabbit anti-Cyclin-D1 (2978) and rabbit anti-cleaved caspase-3 (9664) were bought from Cell Signaling Technology, Inc. (Denvers, MA, USA), and these antibodies prepared and used at 1.25 mg/mL. Mouse anti-b-catenin (SC-7963), anti-VE cadherin (SC-9989 and SC-64586), mouse anti-p120 catenin (SC-23872), anti-DLL4 (SC-28915), mouse anti-p53 (SC-6243), and mouse anti-p21 (SC-397) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), and these antibodies were used at 1.5 mg/mL concentrations. Rabbit anti-LPP1 (AV42146), rabbit-anti-b-catenin (C7738 and C2206), and antiFibronectin were purchased from Sigma (St. Louis, MO, USA), and these antibodies were prepared and used at 1.75 mg/mL concentration. Rat anti-Flk1 (Avas12a1) mAb was purchased from Novus Biologicals (Littleton, CO, USA), used at a concentration of 2.0 mg/mL. Rabbit anti-vWF (AB7356), anti-Cre (69050-3), and thrombin (605206) were purchased from EMD-Millipore (Billerica, MA, USA), and anti-vWF and anti-Cre antibodies were prepared and used at 1.25 mg/mL concentrations. Figure 1A ). These fragments were used in the construction of a gene-targeting vector. The Lpp3 gene targeting strategy entailed incorporation of the recognition sequences for two site-specific recombinases, Cre and Flp, into the Lpp3 gene using homologous recombination. This vector incorporates 1.8 kb fragment containing a PGK-Neomycin resistance cassette that is flanked by Flippase recognition target sites (FRT) into the intron between exons 4 and 5. Exons 3 and 4 of Lpp3 are placed between tandem loxP sites, such that these coding segments can be deleted in vivo in a Cre-recombinase dependent manner ( Figure 1A) . The 5 ′ and 3 ′ arms of homology are needed to allow for homologous recombination. Correctness of targeting construct was determined by DNA sequencing and restriction digests. ES cell clones were identified by PCR using Neomycin (Neo) cassette-specific primer, For-
. Targeted ES cell clones were also confirmed by Southern blot analysis with 5 ′ and 3 ′ probes ( Figure 1A) , and the targeting frequency was 8 out of 384 clones (2.0%). Aggregation, breeding of chimeras, and the germline Lpp3 loxP2Neo/ + were generated by inGenious Targeting cells were plated at a density of 2 × 10 4 cells onto 0.2% gelatine coated 6-well dish in serum-free EndoGro medium supplemented with bFGF, VEGF, and Wnt3a. We also generated Lpp3-deficient ECs from Lpp3 fl/fl embryos; accordingly, Lpp3 fl/fl ECs were infected for 18 h with recombinant adenovirus particle encoding the Cre/RFP, in which the RFP signal was used to assess infection efficiency. These cells were immediately used for flow cytometry, biochemical experiments, and gene expression analyses as previously described. 30 -32 For biochemical experiments, ECs isolated from Flk1 + /CD31 + (doublepositive) cells were grown for 6 days in EndoGro media supplemented with 5% FBS; bFGF (10 ng/mL), VEGF (50 ng/mL), and Wnt3a (50 ng/mL); and insulin, transferrin, and selenium (1× ITS, Gibco-BRL). For proliferation assays, ECs were seeded on cover slips pre-coated with 0.2% gelatine and incubated in media containing BrdU (10 mM) for overnight at 378C in a CO 2 incubator, thereafter stained with anti-BrdU labelling kit (Roche). Figure 7A represents the timeline of BrdU experiment. For quantification, at least 10 microscopic fields were selected randomly, counted and photographed on each coverslip using Zeiss microscope and Canon power shot A640 camera supported by Canon Zoom-in software. Experiments were repeated at least three to five times, with at least three technical replicates.
Whole mount immunohistochemistry
After timed mating, gravid mice were euthanized by cervical dislocation. 33, 34 Embryos harvested by caesarean section from E11.5, E12.5, and E13.5 were fixed in freshly prepared 2% p-formaldehyde in PBS for 4 h at 48C. 32, 33 Whole mount immunohistochemistry protocol has been described by Courtney Griffin lab. 35 Fixed embryos were treated with PBS containing 0.15% H 2 O 2 , 0.1% NaN 3 for 1 h at 48C, thereafter incubated in blocking solution (PBS-MBT, 2% carnation dry milk, 0.2% BSA, 0.6% goat serum, and 0.1% Triton X-100 in PBS, pH 7.4) at 48C for 1 h. Next, the samples were incubated in biotinylated rat anti-mouse CD31 antibody (1:50 in PBS-MBT) for 48 h, followed by wash in PBS-MT (PBS, pH 7.4 containing 2% carnation dry milk and 0.1% Triton X-100) for five times, 1 h each at room temperature. Next, the samples were incubated in 1:200 diluted peroxidase-labelled goat anti-rat IgG (KPL) at 48C for overnight. Next day, samples were washed for five times in PBS-MT for 1 h each at room temperature. Peroxidase-stained embryos were visualized by using a DAB kit (Vector Labs). Stained embryos were immersed in 50% glycerol, and vascular developments of the embryos photographed using Zeiss stereo microscope at room temperature.
TUNEL apoptosis assay
Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick endlabelling (TUNEL) assays were performed on paraffin-embedded sections prepared from E13.5 using EC-specific VasoTACS in situ apoptosis detection kit (Trevigen). 36, 37 For imaging and quantification, 20 microscopic fields were selected randomly, photographed with Zeiss Apotome microscope acquired using AxioVision software at room temperature. TUNEL-positive ECs were quantified in both MT and their WT littermates. Experiments were repeated at least three times.
Immunohistochemistry and microscopy
Staining and microscopy methods have been previously described. 19, 22, 30 In brief, paraffin-embedded sections prepared from E13.5 were rehydrated in graded ethanol then treated with 3% hydrogen peroxide (H 2 O 2 ) for 20 min, next the samples were blocked with 5% normal goat serum diluted in 1× PBS, pH 7.4, for 1 h. Sections were incubated in primary antibodies for 1 h (1:200 dilution, 2.0 mg/mL). After PBS wash, slides were incubated with appropriate secondary antibodies (dilution 1:300) for 1 h at room temperature. Stained sections were examined, images photographed with a Zeiss Apotome fluoroscope, and scored for staining intensity as previously described.
19,22,30
2.7 Transmission electron microscopy E13.5, both WT (B6.tg.Tie2
Cre siblings) and MT, were fixed in 0.1 M cacodylate buffer, pH 7.4. All transmission electron microscopy (TEM) processing were carried out by the University of Illinois at Chicago Research Resources Center Electron Microscopy Service core facility. Images were recorded using JEM-1220 TEM and Erlangshen ESW1000W 785 digital camera supported by Gatan digital micrograph version 1.7.1 software.
Cell culture, shRNA transfection, and western blot analysis
For immunostaining, ECs were plated on coverslips and stained as previously described. 19 -22 Lentivirus shRNA-mediated knockdown was performed as previously described, 29 -31 and efficiency evaluated by western blot (WB) analysis. For WB, cells were solubilized in cell lysis buffer containing 20 mM Tris (pH 7.5), 1.0% Triton X-100, 0.2% NP-40, 1 mM EDTA, and 150 mM NaCl, in presence of freshly added protease inhibitors cocktail as previously described. 19, 22 For quantification, signal band intensity was measured using ImageJ (NIH software). All WB images shown are representative, and the images within comparison groups are obtained from the same nitrocellulose membrane exposed to X-ray films exactly for same time.
Transendothelial electrical resistance assays
To assess EC monolayer barrier integrity, real-time transendothelial electrical resistance (TER) changes in EC monolayer was recorded using the ECIS system (Applied Biophysics, Troy, NY, USA) as previously described. 38, 39 ECs isolated from WT and MT mice and LMVECs were plated on gold electrode (Applied Biophysics) slides for 72 h to make a uniform monolayer. ECs were then treated with control shRNA or Lpp3-shRNA. After 6 h, Lpp3-depleted cells were re-transfected with b-catenin cDNA or p120-catenin cDNA. Plates were then positioned in lock-in amplifier with a constant current of 1.0 mA supplied by a 1 V, 4000 Hz alternating current signal between the small electrode and the larger counter I. Chatterjee et al.
electrode. The voltage between the small and the large electrodes was monitored in all of the different wells and recorded with ECIS-Applied Biophysics software. After 25 min of recording the baseline, the EC monolayers were treated with 50 nM of thrombin, thereafter thrombin-induced changes in resistance was monitored for about next 2 h. Efficiency of shRNA-mediated knockdown and cDNA transfection in HMVEC-L cells was assessed by WB ( Figure 6C ).
Endothelial branching point structure assay
Twenty-four-well dishes were coated with 100 mL Matrigel at 378C for 45 min. Embryonic ECs isolated from E13.5 (as described above) were re-suspended in 200 mL of EndoGro media, thereafter plated onto the Matrigel. After attachment of ECs to the matrix, media containing bFGF (10 ng/mL), VEGF (50 ng/mL), and Wnt3a (50 ng/mL) were added. Thereafter, dishes were returned to 378C humidified CO 2 incubator. After 48 h, branching point structures were evaluated, 10 random microscopic fields at ×20 magnifications were counted, and representative images were photographed with a Zeiss microscope and Canon power shot A640 camera as previously described.
22,30
Quantitative real-time polymerase chain reaction assay
Total RNAs were isolated from ECs with the use of TRIzol reagent (Invitrogen); quantification and assays were performed as previously described. 30, 31 Primer pairs for mouse Lpp3, Lpp2, Cyclin-D1, Fibronectin, VE-cadherin, Flk1, Klf2, Klf4, and Hprt were purchased from IDT DNA (Skokie, IL, USA). Hprt was used as an internal control to correct for the concentration of cDNA in different samples. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed using Power SYBR Green RNA-to-CT TM 1-step kit (Applied Biosystems) using gene-specific primer pairs ( Table 1) .
Statistics
Values are means + SEM. Statistical significances were calculated by standard t-test or one-way analysis of variance with Bonferroni post hoc test for more than two conditions, and values of P , 0.05 were considered statistically significant.
Results
Tie2
cre -mediated Lpp3 deletion causes embryonic lethality in two waves and severe defects in vascular development
The Lpp3 genomic locus, restriction sites, targeting vector schematic, and diagnostic Southern blots of targeted ES cell clones are shown in Figure 1A . Representative PCR genotyping results for WT, Lpp3 loxP2Neo/WT , and Lpp3 loxP2Neo/loxP2Neo mouse tail DNAs are shown in Figure 1B , and a simplified breeding scheme is shown in Figure 1C . To investigate the role of Lpp3 in Tie2 Cre -expressing cellular compartments, female Lpp3 fl/fl mice were crossed with male B6.tg.Tie2
Cre transgenic mice. Tie2
Cre -mediated elimination of exons 3 and 4 generated
Lpp3-null MT embryos, which are expected to be mostly EC specific; however, Lpp3 was also expressed in non-vascular tissues. Through this breeding scheme ( Figure 1C) , we observed early on that pregnant mothers produced only 3 or 4 pups per litter, and the genotype confirmed these pups were either Tie2 Cre or Lpp3 fl/wt . Therefore, timed matings were carried out and embryos were harvested from the pregnant mothers; subsequently, these embryos were subjected to microscopic phenotypic analyses. The microscopic examination provided indication that some of the embryos were blue and some were small (Supplementary material online, Figure S1A -D), and these abnormal embryos died between E8.5 and E10.5 and we considered this as the first wave of lethality. Microscopic analysis of haematoxylin and eosin (H&E)-stained paraffin sections prepared from dead embryos indicated the presence of ECs and red blood cells but poorly developed cardiovascular structures. The analyses of E11.5 to E13.5 indicated that Lpp3 ECKO (also indicated as MT) embryos likely died in utero due to the defects in vascular structures and haemorrhage ( Figure 1D and Supplementary material online, Figure S1E -I), and we attributed this event to the second wave of lethality. To confirm the loss of Lpp3 in ECs, we isolated ECs from these embryos; these ECs showed the absence of the 
were frequently found in utero, indicating late embryonic lethality. Heterozygous mice ( fl-Lpp3 DNeo/WT ) appeared to be phenotypically normal, and their viability was similar to that of WT littermates. To perform phenotypic analyses, WT-and MT-embryos were collected at specific developmental stages ( Table 2 ) and subjected to microscopic analyses. Normal vascular patterning was also seen in normal head and tails at E12.5 (Supplementary material online, Figure S2A-C) . However, in MT embryos, severe haemorrhage was visible in the head region ( Figure 1D , bottom right panels; Supplementary material online, Figure  S2D ). In addition, we observed defective sprouting of blood vessels in the tails of the MT-embryos but not in WT-tails (Supplementary material online, Figure S2E and F). These results indicated that Tie2 Cremediated Lpp3 deletion produces embryonic lethality in two waves.
Embryonic lethality in
Cre ) and MT (Lpp3 ECKO ) embryos revealed no gross abnormalities prior to E11.5. Detailed microscopic analysis of H&E-stained sections of E13.5 MT-embryos revealed severe haemorrhage in the brain cavity. These haemorrhages were most likely one of the main causes of embryonic death. Although it was difficult to precisely determine the primary sites of haemorrhage based on the microscopic examination, the haemorrhages appeared to extend mainly to the frontal regions of the brain cavity. To determine whether vascular leakage was due to an altered EC phenotype, we performed whole-mount staining with a monoclonal anti-CD31 antibody to visualize the vascular system (Figure 2A-H) . Anti-CD31 staining of MT embryos revealed developing neovessels with patches showing haemorrhagic events inside the head region ( Figure 2B -D) . We also observed several blunt-ended vessels; however, there was no such defect in the WT embryos (Figure 2A -D) . Staining with anti-CD31 showed normal vascular development in the WT-eye ( Figure 2E) , whereas the formation of the vascular network in the MT-eye ( Figure 2F ) was not as extensive as that in the WT-eye. The gross vascular network in the MT-eye seemed to be incomplete and often failed to form stable vascular network connections ( Figure 2F ). Retinal neovessel formation occurs immediately after birth, and prior to that, the hyaloid vasculature supplies the inner eye and lens; immediately after birth, these hyaloid vessels start to regress as the neovessels form. The neovessels in the MT-hyaloid were reduced. Anti-CD31 staining of the MT embryos showed haemorrhages in the early vascular plexuses ( Figure 2D ). We also found impaired vascular remodelling in the yolk sac in Lpp3-deficient embryos ( Figure 2G and H). Trabeculation and the growth of compact wall of the myocardium are morphogenetic events that are known to be critical for the development and function of the ventricular walls. In addition, the interactions between ECs in the developing heart and adjacent cardiomyocytes provide intimate signalling cross-talk to control cardiac development, contractile activities, and rhythmicity. Since EC -cardiomyocyte interactions play a key role in cardiac growth, we stained WT-and MT-heart sections with H&E. Examination of the WT-heart showed the presence of apparently normal epicardium, myocardium, and endocardium, with an expected level of trabeculation and the growth of compact wall, and the presence of epicardium ( Figure 3A , B, and G); in contrast, the MT-heart showed significantly decreased trabeculation, insufficient growth of the compact wall, and hypocellular myocardial wall defect accompanied by thin epicardium ( Figure 3C , D, and H). Additional images ( Figure 3E and F) represent MT-embryo showing decreased trabeculation and insufficient growth of compact wall. Together, these results indicate that the Tie2
Cre -mediated deletion of Lpp3 affects embryonic cardiovascular development.
Lpp3-deficient ECs show increased susceptibility to apoptosis
To determine if the vascular defects observed in MT (Lpp3 ECKO ) embryos were due to EC apoptosis, paraffin-embedded sections of E13.5 WT (tg.Tie2
Cre embryo) and MT embryos were subjected to immunochemical staining ( Figure 4A-H) . WT-embryos showed normal (basal) apoptosis ( Figure 4A , C, E, and I), whereas MT embryos exhibited a 40 + 4.5% increase in TUNEL + ECs ( Figure 4B , D, F, and I) in the head region, where vascular leakage and haemorrhagic events were detected. At higher magnification, the WT-sections showed very few TUNEL + ECs, whereas in MT-sections, TUNEL 2 positive cells were mostly ECs ( Figure 4H ). Although VasoTac primarily detects apoptotic ECs, it may also stain smooth muscle cells; nevertheless, Tie2 Cremediated Lpp3 deletion likely also altered smooth muscle cell survival. Next, we isolated ECs from Tie2 Cre (WT) or Lpp3 fl/fl embryos cultured for 4 days. Adenovirus particles encoding Cre/eRFP (red fluorescent protein) were added to these cells and cell extracts prepared after 18 h of infection. The basal expression of the proapoptotic mediator p53 and its target p21 protein was low in WT-ECs, whereas in MT-ECs, their expression levels increased ( Figure 4J ). We also analysed WT and MT protein lysates for the presence of Flk1 and Cre; the findings provided information regarding EC characteristics and Cre expression levels ( Figure 4J ). To examine EC integrity, we performed TEM analysis ( Figure 4K ). TEM analyses of WT-sections revealed normal ECs with intact vascular walls ( Figure 4K ), whereas MT-sections displayed occurrence of membrane blebbing, condensed nuclei, and ( Figure 4K , white arrowheads) and near-apoptotic ECs (Figure 4 , blue asterisk). In addition, staining of lung tissue sections prepared from E13.5 WT-(Supplementary material online, Figure S3A , top panels) and MT-sections (Supplementary material online, Figure S3B , bottom panels) with anti-cleaved caspase-3 showed the presence of apoptotic vascular cells in MT-embryos (Supplementary material online, Figure S3B and C). Furthermore, purified MT-ECs showed strongly positive staining for anti-cleaved caspase-3 (data not shown). Embryos that appeared macroscopically abnormal such as small in size and haemorrhagic, and sometimes resorbed.
Decreased VE-cadherin and fibronectin expression in Lpp3 ECKO ECs
To determine the role of LPP3 in cardiovascular patterning defects, we prepared sections of large blood vessels from E13.5 mouse embryos and immunostained them with anti-VE-cadherin and anti-fibronectin antibodies. As opposed to WT-sections, MT-sections showed decreased expression of VE-cadherin and reduced deposition of fibronectin; however, no appreciable alteration was observed with anti-CD31 ( Figure 5A-D) . Next, we isolated ECs from E12.5 WT-and MT-embryos as described in the methods; the procedure was as reported in previous studies. 30 -32 Endothelial identity was confirmed using flow cytometry analysis with control IgG, anti-CD31, and anti-Flk1 antibodies ( Figure 5E ). Next, using these isolated ECs, we performed a qRT-PCR assay to identify the target genes involved in Lpp3-regulated angiogenesis. After overnight growth factor starvation, total mRNAs were prepared from WT-and MT-ECs, and the expression levels of candidate genes and EC genes in these cells were determined. Notably, in this assay ( Figure 5F ), the basal expression of Lpp3, Lpp2, Cyclin-D1, Flk1, VEcadherin, and fibronectin was readily detectable in WT-ECs, whereas MT-ECs exhibited reduced expression of Lpp3, Cyclin-D1, VE-cadherin, and fibronectin in the ECs that were cultured under serum-free and growth factor-free culture conditions ( Figure 5F ). This result suggests that Cyclin-D1, VE-cadherin, and fibronectin are regulated directly or indirectly by Lpp3. The morphology of WT-and MT-ECs is shown in Figure 5G .
Loss of EC-Lpp3 results in increased susceptibility to endothelial barrier disruption
The interaction of cytoplasmic domain of VE-cadherin with b-catenin and p120ctn proteins are critical for neovessel stability and Images are representative of three independent experiments in which 6 (WT) and 9 (MT) separate embryos were stained with anti-CD31 (n ¼ 6 -9).
LPP3 control of cardiovascular development endothelial barrier function. 3, 4, 6 While examining H&E sections of MT embryos, we also observed defective lung development (data not shown), which was likely due to defective EC integrity. To test the hypothesis that the loss of LPP3 results in increased vascular permeability of LMVECs, we plated LMVECs on gold-plated electrodes and allowed them to form a confluent monolayer; subsequently, a knockdown experiment was performed using the control shRNA and the LPP3-shRNA retroviral particles. The timeline of the experiment is shown in Figure 6A . As shown in Figure 6B , in one group of LPP3-depleted LMVECs, b-catenin cDNA was transfected transiently, whereas in the second group, p120ctn cDNA was transfected. In LPP3-depleted LMVECs, the baseline TER value and the permeability decreased, whereas in the control group, no appreciable changes were observed. The addition of thrombin (50 nM) to the LMVEC monolayer decreased the resistance, which gradually returned to baseline, indicating re-annealing of the LMVEC monolayer. Thrombin significantly decreased the TER of LMVEC monolayers after LPP3 knockdown ( Figure 6B) ; this defect was partially restored following transfection with a retrovirus encoding b-catenin cDNA, whereas p120ctn had no effect. The efficiencies of knockdown and cDNA transfections were analysed by WB ( Figure 6C ). The data suggest that the loss of Lpp3 is incompatible with vascular EC barrier integrity, which can be rescued, in part, by b-catenin but not by p120ctn.
b-catenin, but not p120ctn, restores the effect of Lpp3 loss
Proliferation of ECs and the formation of branching point structures represent hallmarks of angiogenesis. To determine if LPP3 plays a role in these processes, ECs isolated from E13.5 MT and WT embryos were subjected to cell proliferation assays; the timeline of this experiment is shown in Figure 7A . As opposed to 42 + 4.5% incorporation of BrdU observed in WT-ECs, MT-ECs showed only 11 + 3.25% BrdU incorporation ( Figure 7B and D) . However, the decreased proliferation was rescued, in part, by transfection of MT-ECs with a retrovirus particle encoding b-catenin cDNA ( Figure 7B and E). Representative images of BrdU incorporation assays are shown in Figure 7C -E. WB analyses showed decrease in b-catenin, VE-cadherin, cyclin-D1, and fibronectin expression in the MT-ECs; however, the effect of Lpp3 loss was partially restored by b-catenin cDNA transfection ( Figure 7F ). The use of the antifibronectin antibody revealed immature (fast-moving) forms of fibronectin polypeptide species, raising the possibility that LPP3 regulates the maturation of fibronectin at the translational level as well. However, we did not investigate this phenomenon in detail. The expression of the Cre enzyme was determined using anti-Cre antibodies and equal loading with anti-GAPDH antibodies ( Figure 7F , lowermost panels). The relative fold change in WB signal intensities is shown in Figure 7G . Next, we plated WT-ECs, MT-ECs, and MT-ECs receiving b-catenin cDNA . For quantifications, 9-12 embryos were used for WT-(n ¼ 9) and MT-heart (n ¼ 12) sections. From each embryo, at least three H&E stained slides were prepared and examined through ×10 objectives. Each data point in the bar graph ( Figure 3G and H ) represents average of three slides obtained from same embryo (for additional details, please see statistics in the Methods section). *P , 0.05 vs. control.
onto Matrigel to examine the ability of these cells to form branching point structures. The strategy and the timeline of formation of the branching point structures are shown in Figure 7H . As shown in Figure 7I and J, as expected WT-ECs formed branching point structures, whereas MT-ECs (Lpp3 ECKO ) showed a significantly reduced number of branching point structures over the same period ( Figure 7I and K).
Transfection with retrovirus particles encoding b-catenin cDNA-into MT-ECs restored the ability of MT-ECs to form branching point structures, but not to the same extent as that for WT-ECs ( Figure 7I and L).
Discussion
Here, we showed that Lpp3 is essential for some aspects of cardiovascular development in the mouse embryo between E8.5 and E13.5. ECs lining the endothelium of MT embryos show membrane blabbing (white arrows), and presence of intercellular gaps in between adjacent ECs. Bottom panels: magnified view of the blood vessels showing altered EC-EC adhesion structures and frequently shows condensed and fragmented nuclei (*). Magnifications are as shown. E, erythrocyte. Images are representative of three independent experiments in which 9-12 separate embryos were evaluated (n ¼ 9-12).
LPP3 control of cardiovascular development
Embryos lacking EC-Lpp3 developed cardiovascular defects that were different from those described in Lpp3-deletion experiments, 24 -27 demonstrating that signalling pathways mediated through Lpp3 are crucial for normal embryonic development. Specifically, (i) EC-Lpp3 deficiency led to embryonic deaths in two waves; (ii) Lpp3 ECKO embryos developed haemorrhages and apoptotic ECs secondary to the loss of barrier integrity; (iii) in Lpp3 ECKO ECs, the expression of cyclin-D1, VEcadherin, fibronectin, Klf2, and Klf4 decreased; and (iv) the re-expression of b-catenin in Lpp3 ECKO ECs partially restored the effect of the loss of LPP3, whereas p120ctn did not. Together, these results indicate a crucially important role for LPP3 in the maintenance of EC barrier function and angiogenesis. The expression of Lpp3 is seen in ECs at E8.5 in several different vascular bed. 24 In cultured cells, LPP3 is predominantly localized at the cell -cell junctions to maintain the steady-state levels of S1P. 18, 19 We used Tie2
Cre because it is a well-established system, the endothelial expression of Tie2 is known, and its strong expression in ECs occurs as early as E8. one 'Fused/Axin deficiency-like' and the other 'frizzled5 deficiency-like' phenotypes, but their study did not elaborate the exact biochemical mechanisms responsible for these two phenotypes. 24 However, we addressed the ability of LPP3 to titrate b-catenin signalling activities in (i) sub-confluent ECs, LPP3 activated b-catenin signalling, but (ii) confluent ECs, LPP3 down-regulated b-catenin signalling. 22 Here, we show that LPP3 is a positive regulator of cardiovascular development and that it is an essential enzyme; we also provide a new mechanism of regulation of apoptosis by LPP3 and EC barrier integrity via b-catenin signalling activities. Most importantly, a subset of embryos showed a decrease in EC proliferation, accompanied by increased apoptosis, and defects in heart development that were likely secondary to defective EC behaviour. A defect in branching is also likely due to reduced EC migration and inability to form cell-cell adhesion structures. We also observed thickened blood vessels, but these effects were not statistically significant. At times, the Lpp3 ECKO embryos exhibited large avascular regions between blood vessels. The lack of productive angiogenesis suggested that the reciprocal relationship between the levels of cell proliferation and apoptosis, which entails the survival mechanism, is controlled by LPP3. To our knowledge, this study is the first to demonstrate the critical role of LPP3 in the regulation of blood vessel development between E11.5 and E13.5. Neovessel growth and remodelling during embryonic development are regulated by precise signals that determine the orderly nature of angiogenesis. Tie2
Cre -mediated deletion of Lpp3 in ECs and haematopoietic cells in mice resulted in embryonic lethality. A significant number of Lpp3 ECKO embryos died within E11.5-E13.5, and genotyping of ECs collected from these embryos indicated that the expression of Lpp3 was lost, with no appreciable changes in Lpp2 or Lpp1 levels. LPP2 protein levels also did not change in Lpp3-deficient ECs, suggesting that LPP2 cannot compensate for the loss of LPP3. We observed an appreciable number of abnormal embryos at E8.5-10.5 (first wave of lethality); however, detailed analysis of these embryos was difficult due to their small size and fragility. Visual examination of these embryos revealed the presence of blood vessel disruption and localized haemorrhages. CD31 staining revealed the presence of ECs in the WT-and MT-embryos. CD31 staining also confirmed the presence of haemorrhage and defective neovessels in the Lpp3 ECKO embryos.
H&E staining confirmed the presence of defective blood vessels. However, we could not establish the precise haemorrhage or vascular leakage sites. Therefore, we carried out immunofluorescence staining using EC markers. Staining paraffin-embedded sections and fixed cultured cells with antibodies has some limitations in that the specificity and the avidity of each antibody are different and the epitope(s) are often not fully exposed. Thus, to limit over-interpretation of our data, we used only those antibodies that have been used in many studies.
With the use of CD31 staining, it was clear that ECs were present in the Lpp3 ECKO embryos; however, the angiogenic activities of these cells were limited. We observed decreased fibronectin and VE-cadherin levels in the Lpp3 ECKO embryo sections. Staining with anti-smooth muscle a-actin antibodies was inconclusive (data not shown). During angiogenesis, dynamic sprouting ensures that ECs are in contact with each other, e.g. via VE-cadherin-mediated AJs, and it requires the presence of appropriate ECM proteins such as fibronectin. Sprouting ECs secrete high levels of fibronectin 1, 2 ; however, fibronectin is also secreted by several other cell types. Fibronectin is a multifunctional ECM protein, as it not only presents the RGD sequence to integrins but also signals through the FAK and Shc pathways. 43 As fibronectin and VEcadherin proteins regulate multiple aspects of angiogenesis and EC barrier integrity, decreased secretion of fibronectin by Lpp3-defecient ECs could impede adhesion events and integrin signalling, which might induce EC apoptosis. 1 -5,43 Thus, the observed phenotype of increased permeability and haemorrhage in MT embryos is consistent with known deletion primarily altered ECs behaviour due to decreased levels of b-catenin and VE-cadherin proteins and decreased expression of Cyclin-D1, VE-cadherin, fibronectin, Klf2, and Klf4 genes. Because b-catenin is involved in cell adhesion and has the ability to act as a transcriptional regulator, it has been difficult to uncouple the control of transcriptional activities from that of cell adhesion events. Therefore, we were not surprised to find decreased expression of Cyclin-D1, VE-cadherin, Fibronectin, Klf4, and Klf2 genes that are known downstream targets of b-catenin transcriptional activities. Thus, we postulate that Lpp3 deficiency in the vasculature decreases the expression of these genes below the optimal level that is required for normal EC development, as LPP3 likely regulates endothelial responses to athero-relevant haemodynamic forces. 44, 45 Our study provides evidence that Lpp3, at least in ECs and in a subset of haematopoietic cells, plays a pro-survival role in the formation of neovessels during embryonic development. MT-embryos frequently showed striking cardiac defects. MT hearts were poorly developed as only intact structure in these hearts was the thin epicardium; importantly, in the MT-embryos, the myocardium and the endocardium were less developed, with thin ventricular wall and the cardiac cushions clearly absent. The observed insufficient myocardial trabeculation and decreased compact wall were likely to be caused by reduced b-catenin signalling and fibronectin secreted by the Lpp3 ECKO ECs, and due to the disruption of blood vessel formation. Fibronectin deposition and assembly are required for cardiomyocyte migration and proliferation. 1,2,46,47 Fibronectin-mediated a4-integrin signalling has also been shown to control cardiac development. 48 Because endothelial cardiomyocyte interaction is also required for normal cardiac development and growth, EC death may affect cardiomyocyte survival and growth. Recently, S1P has been suggested to act as a negative regulator of angiogenesis at some point during embryonic development. 49, 50 We observed that the Lpp3 ECKO resemble Cattnb fl/fl ::tie2 Cre embryos in their timing of lethality and head haemorrhage phenotype. 5 Thus, it would be interesting to examine if genetic overexpression of EC b-catenin in vivo (i.e., Cattnb lox(ex3)/lox(ex3)
) could rescue any of the haemorrhage or other vascular defects seen in Lpp3 ECKO . Future studies should address this intriguing question. Taken together, our study illuminates a crucially important function of LPP3 in ECs as a positive modifier of cardiovascular development. Three independent genome-wide association study revealed a link between a frequently occurring variation in the LPP3 (PPAP2b) loci and an increased risk of coronary artery disease. 51 -53 Recent review articles have described the putative role of LPP3 to increased risk of cardiovascular disease. 44, 54 Thus, the results presented in this study indicate that the loss of Lpp3 in ECs and in a subset of Tie2-expressing haematopoietic cells impairs the development of functional vasculature. Importantly, we demonstrate that Lpp3 is a modifier of normal embryonic blood vessel development. Our study also reveals an unusual mechanism of a lysolipid phosphatase in the regulation of vascular development; therefore, we propose that LPP3 acts as a 'gatekeeper' of normal EC homeostasis.
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